Claudio Zamagni

7PUBLICATIONS
109CO-AUTHORS
Predictive and prognostic markersTumour immunologyHealth informatics and information systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
Molecular Characterization of Endometrial Cancer Using a Laboratory-Developed Multi-Gene NGS Panel.

|Aug 21, 2026
Pattern-based interpretation of SOX2 expression in ovarian teratomas: avoiding diagnostic pitfalls in the distinction between immature and mature neuroectodermal elements.

|Jul 17, 2026
Tumor-Infiltrating Lymphocytes as a Predictor of Adjuvant Avelumab Efficacy in Patients with High-risk Triple-Negative Breast Cancer.

|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

|Sep 26, 2025
Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer.

Chiara Maura Ciniselli, Elena Conca, Michele Bartoletti

|Aug 12, 2025
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype.

Marco Grillini, Jacopo Lenzi, Claudio Ceccarelli

Pageof 2

Frequent Collaborators

3 joint publications

Giovanni Tallini

3 joint publications

Marco Grillini

3 joint publications

Pierandrea De Iaco

3 joint publications

Caterina Ravaioli